Asset formula

Global Trust Asset Management LLC holds a $132,000 position in The Clorox Company (NYSE:CLX)


Global Trust Asset Management LLC reduced its stake in The Clorox Company (NYSE:CLX – Get Rating) by 32.4% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 952 shares of the company after selling 457 shares during the period. Global Trust Asset Management LLC’s holdings in Clorox were worth $132,000 when it last filed with the Securities and Exchange Commission (SEC).

Several other hedge funds also changed their positions in the company. State Street Corp increased its position in Clorox shares by 4.1% during the fourth quarter. State Street Corp now owns 8,223,034 shares of the company valued at $1,433,768,000 after acquiring 327,488 additional shares last quarter. Geode Capital Management LLC increased its equity stake in Clorox by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 2,331,231 shares of the company worth $405,639,000 after purchasing an additional 54,921 shares last quarter. Bank of New York Mellon Corp raised its position in Clorox shares by 2.0% during the third quarter. Bank of New York Mellon Corp now owns 1,542,002 shares of the company worth $255,369,000 after purchasing an additional 30,655 shares during the period. Stifel Financial Corp increased its position in Clorox by 5.7% in the fourth quarter. Stifel Financial Corp now owns 1,407,022 shares of the company valued at $245,335,000 after acquiring an additional 76,072 shares during the period. Finally, Vaughan Nelson Investment Management LP increased its position in Clorox by 18.6% in the fourth quarter. Vaughan Nelson Investment Management LP now owns 1,281,902 shares of the company valued at $223,512,000 after acquiring an additional 201,306 shares during the period. Institutional investors hold 77.28% of the company’s shares.

Several equity research analysts have recently commented on the stock. StockNews.com began covering Clorox shares in a research note on Thursday, March 31. They issued a “holding” rating on the stock. Wells Fargo & Company lowered its price target on Clorox shares from $130.00 to $120.00 and set an “underweight” rating on the stock in a Tuesday, June 21 research note. Deutsche Bank Aktiengesellschaft cut its target price on Clorox shares from $145.00 to $132.00 and set a “hold” rating for the company in a Tuesday, June 21 research note. Barclays lowered its price target on Clorox from $126.00 to $115.00 and set an “underweight” rating for the company in a Monday May 23 report. Finally, JPMorgan Chase & Co. raised its price target on Clorox from $123.00 to $126.00 in a Thursday, April 14 research note. Nine investment analysts gave the stock a sell rating, five gave the company a hold rating and one gave the company a buy rating. According to MarketBeat, the stock has an average rating of “Reduce” and an average price target of $140.69.

In related news, Director A D. David Mackay sold 1,000 shares in a trade that took place on Thursday, June 2. The shares were sold at an average price of $140.63, for a total value of $140,630.00. As a result of the sale, the administrator now directly owns 600 shares of the company, valued at approximately $84,378. The sale was disclosed in a filing with the Securities & Exchange Commission, accessible via this hyperlink. Additionally, COO Eric H. Reynolds sold 585 shares of the company in a trade that took place on Monday, May 9. The shares were sold at an average price of $154.83, for a total transaction of $90,575.55. As a result of the transaction, the chief operating officer now owns 17,289 shares of the company, valued at approximately $2,676,855.87. The disclosure of this sale can be found here. Insiders own 0.58% of the shares of the company.

CLX shares opened at $140.75 on Monday. The company has a market capitalization of $17.32 billion, a price-earnings ratio of 38.14, a PEG ratio of 4.83 and a beta of 0.18. The Clorox Company has a 12-month low of $120.50 and a 12-month high of $191.75. The company has a quick ratio of 0.40, a current ratio of 0.71 and a debt ratio of 3.28. The stock has a 50-day moving average price of $142.40 and a 200-day moving average price of $151.07.

Clorox (NYSE:CLX – Get Rating) last released its quarterly results on Monday, May 2. The company reported EPS of $1.31 for the quarter, beating the consensus estimate of $0.97 by $0.34. Clorox had a net margin of 6.44% and a return on equity of 92.98%. The company posted revenue of $1.81 billion in the quarter, compared to $1.81 billion expected by analysts. In the same quarter of the previous year, the company achieved EPS of $1.62. Sell-side analysts expect The Clorox Company to post earnings per share of 4.16 for the current fiscal year.

Clorox Company Profile (Get an evaluation)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle and International. The Health and Wellness segment offers cleaning products, such as laundry additives and household cleaning products, primarily under the brands Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex and Formula 409; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare and Clorox Total 360 brands; professional catering products under the Hidden Valley brand; and vitamins, minerals and supplements under the RenewLife, Natural Vitality, NeoCell and Rainbow Light brands in the United States.

Further reading

Want to see which other hedge funds hold CLX? Visit HoldingsChannel.com for the latest 13F filings and insider trading for The Clorox Company (NYSE:CLX – Get Rating).

Institutional ownership by quarter for Clorox (NYSE:CLX)



Get news and reviews for Clorox Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Clorox and related companies with MarketBeat.com’s FREE daily newsletter.


Source link